Global Meeting on Cancer

MEC Global Events cordially invites participants from all over the world to premier Global Meeting on Cancer scheduled during November 13-14, 2020 Virtual Conference which includes major keynote presentations, plenary talks and poster presentation. Cancer 2020 is designed to gather the experts in the field of oncology and related areas.

Cancer 2020 will be focused mainly on the theme: Exploring the Research Advancements in Cancer and its therapy.

 Why to Attend?

Cancer 2020 is the best opportunity for all the oncology and cancer related doctors, oncology professionals, scientists, Radiologists, oncology professionals, surgeons, Physicians, research scholars, students who are working in oncology and its allied areas to explore their scientific research across the globe.

 What are the Sessions?

Cancer Genetics & Genomics

Cancer Immunotherapy & Vaccines

Cancer Metabolism

Breast Cancer

Skin Cancer

Brain Cancer

Lung Cancer

Prostate cancer

Oncology and Computational Oncology

Epigenetics

Cancer Immunology

Cell Signaling & Regulation

Metastasis & Drug Resistance

Stem Cells for Cancer

 Who can Attend?

Oncologists

Haematologists

Research scholars

Students and Young Researchers

Relevant Association and Societies

Business professionals across the globe

Pathologists

Corporate Cancer Research Professional

Software Developing Companies

Radiologists

Chemotherapists

Market Report

The global cancer therapy market is estimated to grow with a CAGR of 8.37% during the forecasted period. Certain factors that are driving the market growth include increasing Patient Assistance Programs (PAPs), increasing government initiatives for cancer awareness, rising prevalence of cancer worldwide, and strong R&D initiatives from key players.

More than 45 million Americans do not have health insurance and millions more are underinsured; eight out of 10 uninsured people are from working families. Among those with health insurance, one out of 10 individuals, 65 years old or younger, and one in three persons over 65 years do not have prescription drug coverage. Hence, Patients Assistance Programs (PAPs) have emerged in an effort to help patients who are lacking health insurance or prescription drug coverage  get the medication they need. These programs are provided by pharmaceutical companies to provide free or low-cost prescription drugs to patients who are suffering from serious illnesses.

 Major Companies

Amgen Inc.

AstraZeneca PLC

Bayer AG

Johnson and Johnson

Merck & Co. Inc